C

Cone Health | Regional Center for Infectious Disease (RCID)

Research site

(Unclaimed)

Location

RCID Research 301 East Wendover Avenue, Ste 111, Greensboro, North Carolina, United States of America

Site insights

Top conditions

Top treatments

Diroximel Fumarate

Rovalpituzumab

I-124 EVuzamitide

Inclisiran

Diuretic

Parent organization

This site is a part of Cone Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 22 total trials

Baroreflex Activation Therapy for Heart Failure (BeAT-HF)

The purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therap...

Active, not recruiting

Heart Failure

Device: BAROSTIM NEO® System

Drug: Medical Management

RADIANCE Continued Access Protocol (RADIANCE CAP)

RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to...

Active, not recruiting

Hypertension

Hypertension, Resistant to Conventional Therapy

Device: Renal Denervation

Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis (REVEAL)

The purpose of this Phase 3, open label, single dose imaging study is to evaluate the efficacy and safety of I-124 evuzamitide (radioactive dye) for...

Enrolling

Cardiac Amyloidosis

Drug: I-124 evuzamitide

VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease (V-INCLUSION)

VictORION-INCLUSION (V-INCLUSION) seeks to evaluate the effectiveness of inclisiran as an innovative therapy with the potential to help bridge care g...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Drug: Inclisiran